HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy

Abstract : In this communication, we report the synthesis and cholinesterase (ChE)/monoamine oxidase (MAO) inhibition of 19 quinolinones (QN1-19) and 13 dihydroquinolinones (DQN1-13) designed as potential multitarget small molecules (MSM) for Alzheimer’s disease therapy. Contrary to our expectations, none of them showed significant human recombinant MAO inhibition, but compounds QN8, QN9, and DQN7 displayed promising human recombinant acetylcholinesterase (hrAChE) and butyrylcholinesterase (hrBuChE) inhibition. In particular, molecule QN8 was found to be a potent and quite selective non-competitive inhibitor of hrAChE (IC50 = 0.29 µM), with Ki value in nanomolar range (79 nM). Pertinent docking analysis confirmed this result, suggesting that this ligand is an interesting hit for further investigation.
Document type :
Journal articles
Complete list of metadata

https://hal-univ-fcomte.archives-ouvertes.fr/hal-03654611
Contributor : Lhassane Ismaili Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 4:59:05 PM
Last modification on : Friday, April 29, 2022 - 3:08:35 AM

Links full text

Identifiers

Collections

Citation

Óscar Bautista-Aguilera, Lhassane Ismaili, Mourad Chioua, Rudolf Andrys, Monika Schmidt, et al.. Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences, MDPI, 2020, 21 (11), pp.3913. ⟨10.3390/ijms21113913⟩. ⟨hal-03654611⟩

Share

Metrics

Record views

2